Blau Farmacêutica Investor Relations Material
Latest events
Q1 2025
Blau Farmacêutica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Blau Farmacêutica S.A
Access all reports
Blau Farmacêutica S.A. develops and manufactures pharmaceuticals with a focus on biotechnology-based products. Its portfolio includes hospital-use medications and therapies for oncology, nephrology, and infectious diseases. The company is headquartered in Cotia, Brazil, and its shares are listed on the B3.
Key slides for Blau Farmacêutica S.A
Q1 2025
Blau Farmacêutica S.A
Q1 2025
Blau Farmacêutica S.A
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
BLAU3
Country
🇧🇷 Brazil